View by Specialty
Log in or Sign up for Free to view tailored content for your specialty!
Sjögren’s Syndrome News
-
Headline News
Senate committee advances NIH, FDA leaders' nominations
March 13, 20252 min read -
Headline News
‘We are going to have difficulty’: Untangling causes of fatigue, long COVID remains elusive
March 14, 20255 min read -
Headline News
Semaglutide, tirzepatide not deemed cost-effective obesity therapies despite benefits
March 14, 20253 min read
-
Headline News
Senate committee advances NIH, FDA leaders' nominations
March 13, 20252 min read -
Headline News
‘We are going to have difficulty’: Untangling causes of fatigue, long COVID remains elusive
March 14, 20255 min read -
Headline News
Semaglutide, tirzepatide not deemed cost-effective obesity therapies despite benefits
March 14, 20253 min read